Purchase Order 75N90022P00550
Award Date 9/2/22
Potential Completion Date 9/30/22
Potential Value $95K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, to provide a MiSeq Next Generation Sequencing system. The MiSeq system will be used by the NIH Clinical Center's Department of Transfusion Medicine/Human Leukocyte Antigen (HLA) Laboratory to perform high-resolution HLA typing in support of organ transplant protocols. The contract has a ceiling...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $266,475.00 order was for a NextSeq 550 Sequencing System, shipping, maintenance, software licenses, and technical support to support the NIH Clinical Center's Department of Transfusion Medicine and its blood collection and research activities. The contract was...
- This $95,931 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq High Throughput Sequencer System. The award did not have a set-aside designation. The MiSeq system will be used in NIAID's Laboratory of Immunoregulation and must be fully compatible with Illumina's existing on-site software, kits, and reagents. Illumina has a history of providing...
- The National Institutes of Health Clinical Center awarded a $279,999.93 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two NextSeq 1000 Sequencing Systems to replace older equipment. The solicitation sought sequencing systems that could automatically generate DNA clusters and perform sequencing, primary, and secondary analysis compatible with existing assays, reagents, consumables, software, and workflows. As the only vendor...
- The NIH Clinical Center awarded a purchase order valued at $256,576.92 to Illumina, Inc. for two MiSeq Sequencing Systems (serial numbers M07700 and M08636) on December 12, 2024. This firm fixed-price contract carries an ultimate completion date of December 11, 2029 and utilizes no set-aside designation. Illumina, a leading biotechnology company headquartered in San Diego, California, specializes in genetic sequencing and genomic analysis technologies. The MiSeq platform represents a...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of a MiSeq System sequencing platform. The contract has a ceiling value of $95,931.00 and a completion date of August 21, 2014. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously provided such products and services to various federal...
- This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the acquisition of an Illumina MiSeq System. The contract has a ceiling value of $95,931.00 and a completion date of August 31, 2019. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents, and has received past prime contract awards from various federal agencies to support their...
- This firm fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq support plan. The $15,388.08 contract is intended to ensure optimal performance and reliability of the MiSeq system to support genomic research and clinical applications at the NHLBI DNA Sequencing and Genomics Core. Illumina, a manufacturer of sequencing and array-based solutions, has previously provided...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of a MiSeq benchtop DNA sequencer system. The total ceiling value of the contract is $119,937.50, with a performance period ending on December 2, 2013. The contract does not have any set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...